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Abstract
Coagulase-negative staphylococci (CoNS) form a thick, multilayered biofilm on foreign bodies and are a major cause of
nosocomial implant-associated infections. Although foreign body infection models are well-established, limited in vivo data
are available for CoNS with small-colony-variant (SCV) phenotype described as causative agents in implant-associated
infections. Therefore, we investigated the impact of the Staphylococcus epidermidis phenotype on colonization of implanted
PVC catheters and abscess formation in three different mouse strains. Following introduction of a catheter subcutaneously
in each flank of 8- to 12-week-old inbred C57BL/6JCrl (B6J), outbred Crl:CD1(ICR) (CD-1), and inbred BALB/cAnNCrl (BALB/c)
male mice, doses of S. epidermidis O-47 wild type, its hemB mutant with stable SCV phenotype, or its complemented mutant
at concentrations of 10
6 to 10
9 colony forming units (CFUs) were gently spread onto each catheter. On day 7, mice were
sacrificed and the size of the abscesses as well as bacterial colonization was determined. A total of 11,500 CFUs of the
complemented mutant adhered to the catheter in BALB/c followed by 9,960 CFUs and 9,900 CFUs from S. epidermidis wild
type in BALB/c and CD-1, respectively. SCV colonization was highest in CD-1 with 9,500 CFUs, whereas SCVs were not
detected in B6J. The minimum dose that led to colonization or abscess formation in all mouse strains was 10
7 or 10
8 CFUs of
the normal phenotype, respectively. A minimum dose of 10
8 or 10
9 CFU of the hemB mutant with stable SCV phenotype led
to colonization only or abscess formation, respectively. The largest abscesses were detected in BALB/c inoculated with wild
type bacteria or SCV (64 mm
2 vs. 28 mm
2). Our results indicate that colonization and abscess formation by different
phenotypes of S. epidermidis in a foreign body infection model is most effective in inbred BALB/c followed by outbred CD-1
and inbred B6J mice.
Citation: Sander G, Bo ¨rner T, Kriegeskorte A, von Eiff C, Becker K, et al. (2012) Catheter Colonization and Abscess Formation Due to Staphylococcus epidermidis
with Normal and Small-Colony-Variant Phenotype Is Mouse Strain Dependent. PLoS ONE 7(5): e36602. doi:10.1371/journal.pone.0036602
Editor: Vance G. Fowler, Duke University Medical Center, United States of America
Received January 12, 2012; Accepted April 9, 2012; Published May 7, 2012
Copyright:  2012 Sander et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by intramural funding from the Center for Molecular Medicine, University of Cologne (CMMC) to EM and GS and in part by a
grant to KB from the Bundesministerium fu ¨r Bildung und Forschung (BMBF), Germany (01KI1009A ‘‘Skin Staph’’ [Susceptibility and Resistance towards Infections]).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was
received for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gunnar.sander@uk-koeln.de
¤ Current address: Pfizer Pharma GmbH, Berlin, Germany
Introduction
The opportunistic pathogen Staphylococcus epidermidis, member of
the group of coagulase-negative staphylococci (CoNS) and usually
colonizing the human skin and mucous membranes, is one of the
most frequently isolated pathogens involved in nosocomial device-
associated infection. Clinical experience with such infections shows
that often neither host defense mechanisms nor antibacterial
therapy are able to cure these bacteria, probably due to the ability
of S. epidermidis to form a thick, multi-layered biofilm on surfaces of
implanted or inserted foreign bodies [1]. Consequently, when
treatment fails, catheters or prostheses have to be replaced.
The bacterial genetic and regulatory factors leading to biofilm
formation has been investigated in several studies and the concept
of cell-density-dependent quorum sensing has been identified as an
important factor for bacterial communication and induction of the
formation of biofilm communities. In contrast to S. aureus, S.
epidermidis produces only a limited amount of toxins and
degradative exoenzymes. As such, investigations of S. epidermidis
biofilms and its potential as a virulence factor were intensively
performed in animal models in the past three decades, but resulted
in conflicting data with respect to biofilm formation. Reports
differed depending on the bacterial strain, the presence of foreign
bodies such as catheters, tissue damaging caused by insertion or
removal of foreign bodies, and the choice of suitable mouse strains
[2,3,4,5,6].
The recovery of small-colony variants (SCVs) of CoNS and
their involvement in device-related infection, including pacemak-
er-related infections, became eminent in the past decade [7,8,9].
SCVs are characterized as small-growing subpopulations of
bacteria with changed physiological and biochemical traits, often
correlated with auxotrophisms for menadione, thymidine and/or
hemin [10]. SCVs have been associated with chronic, long-lasting
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36602and recurrent infections, and it was suggested that this property
was linked to the ability of SCVs to survive intracellularly, thereby
being protected from the host immune system [11,12]. Compared
to its normal phenotype counterpart, an augmented expression of
polysaccharide intercellular adhesin, the main component of S.
epidermidis biofilms, was detected in a hemB mutant with SCV
phenotype [13]. The influence of the bacterial phenotype on
biofilm formation, virulence, and on the potential to cause chronic
and recurrent infection has not been investigated in vivo to date.
In order to elucidate the role of the bacterial phenotype on
infection, the importance of a critical infectious dose and the strain
of mouse as host used in such studies, we established a bacterial
phenotype-, dose-, and host-dependent S. epidermidis foreign-body-
infection model.
Materials and Methods
Bacterial strains, growth conditions, and growth curves
Wild-type S. epidermidis O-47 with normal phenotype, its hemB
mutant with SCV phenotype, and its complemented mutant
displaying the wild-type phenotype were grown on tryptic-soy-agar
(TSA, Sigma Aldrich, Germany) or in tryptic-soy-broth (TSB,
Sigma Aldrich) at 37uC and aerated at 180 rpm [13]. Bacteria
from overnight cultures were inoculated 1:100 in a medium-to-
flask ratio of 1:10 and grown to cell densities appropriate for the
bacterial doses required. Antibiotics were purchased from Sigma
and were added to the medium at final concentrations of 5 mg/ml
erythromycin to the hemB and complemented mutant, because of
introduced resistance cassettes [13]. The latter was also supple-
mented with 10 mg/ml chloramphenicol [13]. Growth curves were
determined by measuring the optical density at l=578 nm over
12 hours. Live-cell determination was performed by plating
adequate dilutions of growing cultures on TSA each hour and
counting the number of counting colony-forming units (CFU) after
at least 24 h of incubation as described previously [14].
Mice and Husbandry
Inbred C57BL/6JCrl (B6J), outbred Crl:CD1(ICR) (CD-1), and
inbred BALB/cAnNCrl (BALB/c) mice were introduced via
embryo transfer and bred in a full barrier unit at the CMMC
animal facility. Breeding colonies were kept in individually
ventilated cages (IVCs, Tecniplast, Italy) at a temperature of 20
to 24uC, humidity of 50 to 60%, 60 air exchanges per hour and a
12/12-hour light/dark cycle. Wood shavings (Ssniff, Germany)
were provided as bedding. Mice were fed a standardized mouse
diet (1314, Altromin, Germany) and provided drinking water ad
libitum. All materials, including IVCs, lids, feeders, bottles,
bedding, and water were autoclaved before use. Sentinel mice
were investigated and monitored negative for all murine infectious
agents including S. epidermidis. Experimental and control mice were
kept in IVCs under negative pressure and the conditions stated
above. All animal manipulations were performed in a class II
laminar flow biological safety cabinet (Tecniplast).
Foreign-body-infection model
A foreign-body-infection model was performed as described
previously with modifications [6]. Briefly, male mice, aging 8 to 12
weeks, were anaesthetized, shaved dorsally, and the skin was
disinfected with Cutasept (Bode, Germany). A 0.5-cm incision in
each flank was made and two 1-cm long sterile PVC catheter
segments were implanted subcutaneously (Figure 1A, I). Doses
from PBS-washed overnight cultures of S. epidermidis O-47, its hemB
mutant with stable SCV phenotype, or its complemented mutant
at concentrations of 10
6,1 0
7,1 0
8 or 10
9 CFUs per 50 ml in 0.9%
NaCl were gently spread onto each catheter (one dose per mouse;
two catheters per mouse). Wounds were closed with absorbable
sutures and wound clips. For each infection dose and bacterial
strain, four mice were inoculated (overall 48 mice per strain). Each
of additional four negative controls received 50 ml of 0.9% NaCl
per catheter. An aliquot of the bacterial suspension used was
subsequently streaked out in appropriate dilutions on TSA to
confirm doses. On day 7, mice were sacrificed by cervical
dislocation and the abscesses were measured (Figure 1A, II; 1B V).
To determine the number of adherent bacteria, catheters were
removed and washed twice with PBS (n=7 for groups with
bacteria; n=3 for negative controls). Tween-EDTA buffer was
added prior to 3 minutes of sonication and vortexing. The
supernatant and adequate dilutions were streaked out on TSA,
incubated at 37uC for at least 48 hours and CFUs were counted. A
drop of blood, wound (approx. 5 mm63 mm skin biopsy
surrounding incision), and abscess samples were incubated in
10 ml TSB for at least 48 h. Single colonies from positive cultures
were isolated on TSA. Identification and confirmation of
subcultured bacteria were performed by susceptibility tests for
the hemB mutant and the complemented mutant, and additionally
16S ribosomal RNA gene sequencing. The biofilm formation on
catheters (n=1 for each dose) was determined by safranin staining
as described previously [15,16,17]. Briefly, catheters were air-dried
overnight, stained in 0.1% safranin for 30 s, air-dried, and the
staining intensity was monitored.
Statistical analysis
Statistical analysis was performed using the unpaired Student t-
test. Values of p,0.05 were considered as significant.
Ethic statement
All animal experiments were conducted and approved by local
authorities (‘‘Landesamt fu ¨r Natur, Umwelt und Verbrau-
cherschutz’’, North Rhine Westphalia; reference number 87-
51.04.2010.A353) in accordance with German law of animal
protection (18
th of May 2006 (BGBI.I S. 1206 1313) which was
amended on the 18
th of December 2007 (BGBI I S. 3001; 2008,
47).
Results
All mice included in this study showed no symptoms of systemic
infection during the 7-day-period of the investigation. Wound
healing in infected mice was neither affected nor retarded
compared to controls. However, mice lost 7% (B6J, CD-1) to
9% (BALB/c) body weight until the end of experiment when
infected with S. epidermidis normal phenotype in doses of 10
9 (data
not shown, p.0.05).
No abscess formation was observed on day 7 at doses of 10
6 and
10
7 CFUs per catheter. Data for abscess formation on day 7 for all
three mouse strains at doses of 10
8 and 10
9 CFUs of S. epidermidis
O-47 or the complemented mutant are presented in Table 1. At
this dose, abscesses detected from O-47 infection were significantly
larger in BALB/c, measuring 22.5 mm
2, compared to the
abscesses from CD-1 and B6J. Figure 1B, III-V shows represen-
tative abscess formation with S. epidermidis O-47 in the three
different mouse strains inoculated with doses of 10
7–10
9 bacteria
per catheter. Abscess formation was not observed in all mice below
a dose of 10
8 hemB mutant bacteria displaying the SCV-
phenotype. Starting at a dose of 10
9, the hemB mutant resulted
in abscess formation in all mouse strains with sizes being
significantly different among all three strains, but smaller
compared to abscesses due to S. epidermidis O-47. Compared to
Infection with S. epidermidis Phenotypes in Mice
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an infectious dose of 10
9 of the complemented mutant (69 mm
2,
p,0.05).
As shown in Table 1, an inoculation dose of 10
9 CFUs per
catheter resulted in a recovery of 11,524 CFUs of the comple-
mented mutant from BALB/c followed by 9,960 CFUs and
9,900 CFUs of S. epidermidis O-47 from BALB/c and CD-1,
respectively. Colonization with the hemB mutant displaying the
SCV phenotype was most effective in CD-1 with 9,540 CFUs at a
dose of 10
9 CFUs per catheter, whereas no S. epidermidis hemB
mutant bacteria were detected in B6J (p,0.05). The number of
bacteria recovered at lower doses of 10
6 and 10
7 ranged from a
minimum of zero (CD-1 including all three bacterial strains and
BALB/c with the hemB mutant at a dose of 10
6 bacteria per
catheter) to a maximum colonization of 1,230 CFUs (BALB/c
infected with the complemented mutant, see Table S1).
In Figure 1B, VI–VIII, safranin staining of representative
catheters is shown. Biofilm formation by bacteria was detected at
doses of 10
8 and 10
9 bacteria per catheter, whereas none was
observed at doses of 10
6 and 10
7 (data not shown). With increasing
number of adherent bacteria, the red staining became more
intensive. Negative controls had the same intensity of staining as
shown in Figure 1B, VI.
The expected bacteria were solely confirmed in all samples of
abscess and in wound cultures where catheter colonization was
observed. All blood cultures remained negative.
Discussion
Although studies investigating the virulence of S. epidermidis in
foreign-body-infection models in different mouse hosts have been
performed [2,3,4,5,6], we report for the first time an attenuation of
colonization and abscess formation in mice infected with an SCV
phenotype of S. epidermidis compared to the normal phenotype in
three different immunocompetent mouse strains. As it is still
unknown whether SCV formation is solely due to bacterial
adaption to host or intracellular conditions, and/or is the result of
mutations, we performed this model of acute foreign-body-
infection for an observation period of seven days. [12,18,19,20].
The results reveal an S. epidermidis dose-dependent colonization
of catheters in immunocompetent mice. Neither the dose of 10
6
nor 10
7 led to significant replication of bacteria in all three mouse
strains probably due to the fact that adherence to abiotic surfaces
is mainly mediated through biofilm formation and expression of
adhesins, which lead to better survival in the host [21]. Quorum
sensing, which depends on cell density, might explain colonization
of catheters at a minimum dose of 10
8 bacteria, which seems to be
the initial dose required for inducing effective biofilm formation in
this model. Compared to doses of 10
6, which often have been used
in S. aureus animal models, the high dose of S. epidermidis used in our
model is probably due to the fact that S. epidermidis lacks mass of
virulence factors, which are present in S. aureus, and its versatile
potential to evade host defense mechanisms [22,23].
As described in several studies for S. aureus, the hemB mutant
with SCV phenotype differs in virulence compared to the normal
phenotype depending on the in vitro or in vivo model used
[12,24,25]. S. aureus hemB mutants have been shown to survive
intracellularly and display reduced virulence in vitro [12]. Although
the S. epidermidis hemB mutant is described to produce more biofilm
than the normal phenotype in vitro, in the present study it does not
colonize catheters at amounts comparable to that of the normal
phenotype with the exception of CD-1 mice and at a dose of 10
8
bacteria in BALB/c mice. This is confirmed by the observation
that abscesses from S. epidermidis displaying the SCV phenotype are
smaller than those formed by the normal phenotype. As such, our
in vivo results do not confirm previous in vitro findings [13]. This is
most likely due to a combination of defects in electron transport,
resulting in growth retardation which in vivo leads to reduced
biofilm formation and might also lead in consequence to a reduced
survival in the mouse. A possible intracellular survival of the S.
Figure 1. Post-operative view of mice, abscesses, and biofilm staining of catheters. Figure 1A, I: Implantation of a 1-cm long sterile PVC
catheter segment subcutaneously subsequent to anesthetizing, shaving, and making a small incision in each flank of the mouse. Figure 1A, II. Abscess
formation in a mouse 7 days post inoculation with S. epidermidis O-47. Figure 1B: Subcutaneous abscesses from mice 7 days after inoculation of S.
epidermidis O-47; III) BALB/c mouse with a dose of 10
7, IV) CD-1 mouse with a dose of 10
8, and V) B6J mouse with a dose of 10
9 CFUs and safranin-
stained PVC catheters from BALB/c mice 7 days after inoculation of S. epidermidis O-47; VI) dose of 10
7, VII) dose of 10
8, and VIII) dose of 10
9 CFUs.
doi:10.1371/journal.pone.0036602.g001
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not excluded but needs further studies [11,25]. However,
standardized in vitro conditions differ not only in nutrition
availability, oxygen- and salt concentration, pH, but also in the
influence and attack of the immune system to growing bacteria in
vivo. Thus, the difference between in vitro and in vivo findings is not
quite surprising.
The observation that the complemented mutant does not
behave exactly as S. epidermidis O-47 (see Table 1) in terms of
catheter colonization and abscess formation may be due to the
fitness-related fact that this mutant expresses two additional
resistance genes, namely, erythromycin and chloramphenicol.
In general, all mice showed no symptoms of systemic infection.
Bacteria were not detected in blood indicating that mice were
infected only locally. We can not exclude that a possible
dissemination to other tissues or blood might occur afterwards.
It is possible that a critical cell density in the biofilm community
leads to detachment and spreading of bacteria which was not
achieved during 7 days of experiment [26,27,28]. In addition, the
area of the skin in the periphery of the abscess did not show any
pathological lesions, and wound healing was not delayed.
Our results indicate that colonization of catheters and abscess
formation by different phenotypes of S. epidermidis in a subcuta-
neous foreign-body-infection model is most effective in inbred
BALB/c followed by outbred CD-1 and inbred B6J mice.
Different results with immunocompetent strains of mice have
been reported previously [2,3,4,5,6,29] but the underlying
molecular mechanisms are mostly unknown. Nevertheless, the
different potential of S. epidermidis strains to produce biofilm and
the different methods for determination of colonization also
contribute to the differences in results obtained by different
authors [2,3,4,5,6]. Furthermore, the route and site of infection in
addition to host-dependent factors play a major role [29,30,31]. In
a subcutaneous infection model without a foreign body where
2610
7 CFUs of S. aureus SH1000 were inoculated in the left hind
footpad of 8–12-week old mice, Nippe et al. showed that, in
contrast to our findings, B6J mice were more susceptible to S.
aureus than BALB/c mice, most probably due to strain-dependent
differences in granulocyte recruitment during infection [29].
Granulocyte recruitment and S. epidermidis biofilm formation may
be the reason for faster abscess formation in BALB/c mice than in
B6J mice in our study (see Table 1). Surrounded by the abscess the
bacteria might be protected from other immune components and
may therefore have a better survival chance compared to the
situation in B6J at least during the seven day observation period.
Thus, when immunocompetent strains are needed for subcutane-
ous foreign-body-infection models, we recommend using BALB/c
mice at a dose of at least 10
9 S. epidermidis O-47 per catheter.
In conclusion, the present study provides further information on
choice of mouse strain with regard to bacterial phenotype variants
in an S. epidermidis infection model. An elucidation of molecular
differences in vivo between normal and SCV phenotype, immune
modulation of the host during infection, and differences between
the susceptibility in different mouse strains will be helpful in future
investigations involving bacterial and host factors in establishing
infections.
Supporting Information
Table S1 Colonization of catheters according to dose of three
Staphylococcus epidermidis strains in inbred C57BL/6JCrl, outbred
Crl:CD1(ICR), and inbred BALB/cAnNCrl mice
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